Find Scholarly Works

Search concepts
Selected Filters
2010
51 Citations (Scopus)

A discrete event simulation model to evaluate operational performance of a colonoscopy suite

Berg, B., Denton, B., Nelson, H., Balasubramanian, H., Rahman, A., Bailey, A. & Lindor, K., May 2010, In : Medical Decision Making. 30, 3, p. 380-387 8 p.

Research output: Contribution to journalArticle

Colonoscopy
Patients' Rooms
Resource Allocation
Cause of Death
Colorectal Neoplasms
56 Citations (Scopus)

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis

Silveira, M. G., Brunt, E. M., Heathcote, J., Gores, G. J., Lindor, K. & Mayo, M. J., Jul 2010, In : Hepatology. 52, 1, p. 349-359 11 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Medical Societies
Patient Selection
Liver Diseases
Research Design
18 Citations (Scopus)

A pilot trial of high-dose ursodeoxycholic acid in nonalcoholic steatohepatitis

Adams, L. A., Angulo, P., Petz, J., Keach, J. & Lindor, K., Sep 2010, In : Hepatology International. 4, 3, p. 628-633 6 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Aspartic Acid
Alanine
Therapeutics
Withholding Treatment
17 Citations (Scopus)

A short version of a HRQoL questionnaire for Italian and Japanese patients with Primary Biliary Cirrhosis

Montali, L., Tanaka, A., Riva, P., Takahashi, H., Cocchi, C., Ueno, Y., Miglioretti, M., Takikawa, H., Vecchio, L., Frigerio, A., Bianchi, I., Jorgensen, R., Lindor, K., Podda, M. & Invernizzi, P., Oct 2010, In : Digestive and Liver Disease. 42, 10, p. 718-723 6 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Quality of Life
Principal Component Analysis
Focus Groups
Self Report
72 Citations (Scopus)

Autoimmune hepatitis-PBC overlap syndrome: A simplified scoring system may assist in the diagnosis

Neuhauser, M., Bjornsson, E., Treeprasertsuk, S., Enders, F., Silveira, M., Talwalkar, J. & Lindor, K., Feb 2010, In : American Journal of Gastroenterology. 105, 2, p. 345-353 9 p.

Research output: Contribution to journalArticle

Autoimmune Hepatitis
Biliary Liver Cirrhosis
Esophageal and Gastric Varices
Liver
Portal Hypertension

Autoimmune Liver Diseases

Talwalkar, J. A. & Lindor, K., Aug 31 2010, Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, p. 250-260 11 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Biliary Liver Cirrhosis
Autoimmune Diseases
Liver Diseases
66 Citations (Scopus)

Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression

Sinakos, E., Marschall, H. U., Kowdley, K. V., Befeler, A., Keach, J. & Lindor, K., Jul 2010, In : Hepatology. 52, 1, p. 197-203 7 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Bile Acids and Salts
Disease Progression
Lithocholic Acid
9 Citations (Scopus)

Commentary: Improving medical education during financially challenging times

Lindor, K., Pawlina, W., Porter, B. L., Viggiano, T. R., Grande, J. P., Barrier, P. A., Swanson, J. A. & Buman, K. F., Aug 2010, In : Academic Medicine. 85, 8, p. 1266-1268 3 p.

Research output: Contribution to journalArticle

Medical Education
Medical Schools
Students
school
education
8 Citations (Scopus)

Comparing the simplified and international autoimmune hepatitis group criteria in primary sclerosing cholangitis

Chandok, N., Silveira, M. G. & Lindor, K., Feb 2010, In : Gastroenterology and Hepatology. 6, 2, p. 108-112 5 p.

Research output: Contribution to journalArticle

Autoimmune Hepatitis
Sclerosing Cholangitis
Liver Diseases
Ursodeoxycholic Acid
Autoantibodies
1 Citation (Scopus)

Diagnostic and therapeutic advances in hepatology: A new feature in the journal

Kamath, P. S. & Lindor, K., Feb 2010, In : Hepatology. 51, 2, p. 363 1 p.

Research output: Contribution to journalArticle

Gastroenterology
Liver Diseases
Therapeutics

Diagnostic utility of chromosome 17 and p16 abnormalities in fluorescence in situ hybridization tests in primary sclerosing cholangitis: Reply

Bangarulingam, S. Y., Björnsson, E., Enders, F., Barr Fritcher, E. G., Gores, G., Halling, K. C. & Lindor, K., Jul 2010, In : Hepatology. 52, 1, p. 394-395 2 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Chromosomes, Human, Pair 17
Fluorescence In Situ Hybridization
241 Citations (Scopus)

Drug-induced autoimmune hepatitis: Clinical characteristics and prognosis

Björnsson, E., Talwalkar, J., Treeprasertsuk, S., Kamath, P. S., Takahashi, N., Sanderson, S., Neuhauser, M. & Lindor, K., Jun 2010, In : Hepatology. 51, 6, p. 2040-2048 9 p.

Research output: Contribution to journalArticle

Chemical and Drug Induced Liver Injury
Autoimmune Hepatitis
Nitrofurantoin
Minocycline
Immunosuppression
14 Citations (Scopus)
Bile Acids and Salts
Pregnancy
Ursodeoxycholic Acid
Pruritus
Taurodeoxycholic Acid
31 Citations (Scopus)

Fatigue in primary biliary cirrhosis

Abbas, G., Jorgensen, R. A. & Lindor, K., Jun 2010, In : Nature Reviews Gastroenterology and Hepatology. 7, 6, p. 313-319 7 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Pruritus
Natural History
Liver Cirrhosis
17 Citations (Scopus)

Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up

Björnsson, E., Kalaitzakis, E., Neuhauser, M., Enders, F., Maetzel, H., Chapman, R. W., Talwalkar, J., Lindor, K. & Jorgensen, R., Feb 2010, In : Liver International. 30, 2, p. 251-258 8 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Fatigue
Mortality
Confidence Intervals
Transplantation
2 Citations (Scopus)

Is there a role for tetrathiomolybdate in the treatment of primary biliary cirrhosis?

Silveira, M. G. & Lindor, K., Mar 2010, In : Translational Research. 155, 3, p. 120-122 3 p.

Research output: Contribution to journalArticle

tetrathiomolybdate

Jaundice and Pruritus: A Diagnostic Approach

Gossard, A. A. & Lindor, K., Aug 31 2010, Practical Gastroenterology and Hepatology: Liver and Biliary Disease. Wiley-Blackwell, p. 87-94 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Pruritus
Jaundice
Liver Diseases
Bilirubin
Skin
17 Citations (Scopus)

Latest and emerging therapies for primary biliary cirrhosis and primary sclerosing cholangitis

Zein, C. O. & Lindor, K., Feb 2010, In : Current Gastroenterology Reports. 12, 1, p. 13-22 10 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Biliary Liver Cirrhosis
Ursodeoxycholic Acid
Therapeutics
Cholestasis

Linking medical education and patient care.

Lindor, K. & Porter, B. L., Nov 2010, In : Minnesota Medicine. 93, 11

Research output: Contribution to journalArticle

Organizational Objectives
Mentors
Clinical Competence
Patient Education
Medical Education
119 Citations (Scopus)

Long-term outcomes of positive fluorescence in situ hybridization tests in primary sclerosing cholangitis

Bangarulingam, S. Y., Bjornsson, E., Enders, F., Barr Fritcher, E. G., Gores, G., Halling, K. C. & Lindor, K., Jan 2010, In : Hepatology. 51, 1, p. 174-180 7 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Fluorescence In Situ Hybridization
Cholangiocarcinoma
Tetrasomy
Trisomy
8 Citations (Scopus)

Moexipril for treatment of primary biliary cirrhosis in patients with an incomplete response to ursodeoxycholic acid

Charatcharoenwitthaya, P., Talwalkar, J. A., Angulo, P., Gossard, A. A., Keach, J. C., Petz, J. L., Jorgensen, R. A. & Lindor, K., Feb 2010, In : Digestive Diseases and Sciences. 55, 2, p. 476-483 8 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Alkaline Phosphatase
Liver
Aspartate Aminotransferases
11 Citations (Scopus)

Pharmacological treatment of biliary cirrhosis with ursodeoxycholic acid

Abbas, G. & Lindor, K., Feb 2010, In : Expert Opinion on Pharmacotherapy. 11, 3, p. 387-392 6 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Biliary Liver Cirrhosis
Pharmacology
Therapeutics
Liver Transplantation
1 Citation (Scopus)

Practical Gastroenterology and Hepatology: Liver and Biliary Disease

Talley, N. J., Lindor, K. & Vargas, H. E., Aug 31 2010, Wiley-Blackwell.

Research output: Book/ReportBook

Gastroenterology
Liver Diseases
Color

Preface

Talley, N. J., Lindor, K. & Vargas, H. E., Aug 31 2010, In : Unknown Journal.

Research output: Contribution to journalArticle

40 Citations (Scopus)

Primary sclerosing cholangitis: Overview and update

Mendes, F. & Lindor, K., Nov 2010, In : Nature Reviews Gastroenterology and Hepatology. 7, 11, p. 611-619 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
End Stage Liver Disease
Cholangiocarcinoma
Immunologic Factors
Liver Transplantation
47 Citations (Scopus)

Recurrent primary biliary cirrhosis after liver transplantation

Silveira, M. G., Talwalkar, J. A., Lindor, K. & Wiesner, R. H., Apr 2010, In : American Journal of Transplantation. 10, 4, p. 720-726 7 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Liver Transplantation
Ursodeoxycholic Acid
Graft Survival
Immunosuppression

The possible link between the thyroid and autoimmune liver diseases: Reply

Silveira, M. G. & Lindor, K., Sep 2010, In : Liver International. 30, 8, p. 1240-1241 2 p.

Research output: Contribution to journalArticle

Autoimmune Diseases
Liver Diseases
Thyroid Gland
17 Citations (Scopus)

The predictors of the presence of varices in patients with primary sclerosing cholangitis

Treeprasertsuk, S., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Schmoll, J., Hoskin, T., Thapa, P., Enders, F. & Lindor, K., Apr 2010, In : Hepatology. 51, 4, p. 1302-1310 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Varicose Veins
Platelet Count
Bilirubin
Endoscopy
14 Citations (Scopus)

Treatment options for primary sclerosing cholangitis

Sinakos, E. & Lindor, K., Aug 2010, In : Expert Review of Gastroenterology and Hepatology. 4, 4, p. 473-488 16 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Ursodeoxycholic Acid
Liver Transplantation
Pathologic Constriction
Fibrosis
2011
101 Citations (Scopus)

Alkaline phosphatase normalization is associated with better prognosis in primary sclerosing cholangitis

Stanich, P. P., Björnsson, E., Gossard, A. A., Enders, F., Jorgensen, R. & Lindor, K., Apr 2011, In : Digestive and Liver Disease. 43, 4, p. 309-313 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Alkaline Phosphatase
Ursodeoxycholic Acid
Cholangiocarcinoma
Serum
12 Citations (Scopus)

A major step towards effective treatment evaluation in primary biliary cirrhosis

Beuers, U. & Lindor, K., Dec 2011, In : Journal of Hepatology. 55, 6, p. 1178-1180 3 p.

Research output: Contribution to journalArticle

Cholagogues and Choleretics
Ursodeoxycholic Acid
Biliary Liver Cirrhosis
9 Citations (Scopus)

A model for integration of formal knowledge and clinical experience: The Advanced Doctoring course at Mayo Medical School

Dyrbye, L. N., Starr, S. R., Thompson, G. B. & Lindor, K., Sep 2011, In : Academic Medicine. 86, 9, p. 1130-1136 7 p.

Research output: Contribution to journalArticle

Medical Schools
Medical Students
Students
medical student
school
17 Citations (Scopus)

Antibiotics for the treatment of primary sclerosing cholangitis

Elfaki, D. A. H. & Lindor, K., May 2011, In : American Journal of Therapeutics. 18, 3, p. 261-265 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Anti-Bacterial Agents
Therapeutics
Bacteremia
Bile Ducts

Autoimmune liver diseases

Abbas, G. & Lindor, K., Jan 2011, Autoimmune Disorders: Symptoms, Diagnosis and Treatment. Nova Science Publishers, Inc., p. 1-34 34 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Autoimmune Hepatitis
Sclerosing Cholangitis
Autoimmune Diseases
Biliary Liver Cirrhosis
Liver Diseases
55 Citations (Scopus)

B cell depletion therapy exacerbates murine primary biliary cirrhosis

Dhirapong, A., Lleo, A., Yang, G. X., Tsuneyama, K., Dunn, R., Kehry, M., Packard, T. A., Cambier, J. C., Liu, F. T., Lindor, K., Coppel, R. L., Ansari, A. A. & Gershwin, M. E., Feb 2011, In : Hepatology. 53, 2, p. 527-535 9 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Cell- and Tissue-Based Therapy
B-Lymphocytes
Cholangitis
Antibodies
60 Citations (Scopus)

Bone disease in patients with primary sclerosing cholangitis

Angulo, P., Grandison, G. A., Fong, D. G., Keach, J. C., Lindor, K., Bjornsson, E. & Koch, A., Jan 2011, In : Gastroenterology. 140, 1, p. 180-188 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Bone Diseases
Osteoporosis
Inflammatory Bowel Diseases
Confidence Intervals
165 Citations (Scopus)

Cancer surveillance in patients with primary sclerosing cholangitis

Razumilava, N., Gores, G. J. & Lindor, K., Nov 2011, In : Hepatology. 54, 5, p. 1842-1852 11 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Gallbladder Neoplasms
Neoplasms
Cholangiocarcinoma
Inflammatory Bowel Diseases
44 Citations (Scopus)

Colon Neoplasms Develop Early in the Course of Inflammatory Bowel Disease and Primary Sclerosing Cholangitis

Thackeray, E. W., Charatcharoenwitthaya, P., Elfaki, D., Sinakos, E. & Lindor, K., Jan 2011, In : Clinical Gastroenterology and Hepatology. 9, 1, p. 52-56 5 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Inflammatory Bowel Diseases
Colonic Neoplasms
Guidelines
Colonoscopy
25 Citations (Scopus)

Current management of primary sclerosing cholangitis in pediatric patients

Ibrahim, S. H. & Lindor, K., 2011, In : Pediatric Drugs. 13, 2, p. 87-95 9 p.

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Pediatrics
Ursodeoxycholic Acid
End Stage Liver Disease
Cholangiography
18 Citations (Scopus)

Current therapies for nonalcoholic fatty liver disease

Gossard, A. A. & Lindor, K., Dec 2011, In : Drugs of Today. 47, 12, p. 915-922 8 p.

Research output: Contribution to journalArticle

Exercise
Weight Loss
Therapeutics
End Stage Liver Disease
Bariatric Surgery

Eyewitnesses to history and participants as well

Lindor, K., Dec 2011, In : Hepatology. 54, 6, p. 1897 1 p.

Research output: Contribution to journalArticle

History
38 Citations (Scopus)

Farnesoid X receptor agonists for primary biliary cirrhosis

Lindor, K., May 2011, In : Current Opinion in Gastroenterology. 27, 3, p. 285-288 4 p.

Research output: Contribution to journalArticle

Biliary Liver Cirrhosis
Liver Diseases
Therapeutic Uses
Cytoplasmic and Nuclear Receptors
Bile Acids and Salts
119 Citations (Scopus)

Gender differences in academic productivity and leadership appointments of physicians throughout academic careers

Reed, D. A., Enders, F., Lindor, R., McClees, M. & Lindor, K., Jan 2011, In : Academic Medicine. 86, 1, p. 43-47 5 p.

Research output: Contribution to journalArticle

academic career
gender-specific factors
Appointments and Schedules
productivity
physician
21 Citations (Scopus)

Hepatic fibrosis and the renin-angiotensin system

Abbas, G., Silveira, M. G. & Lindor, K., Nov 2011, In : American Journal of Therapeutics. 18, 6

Research output: Contribution to journalArticle

Renin-Angiotensin System
Fibrosis
Liver
Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
59 Citations (Scopus)

High-dose ursodeoxycholic acid increases risk of adverse outcomes in patients with early stage primary sclerosing cholangitis

Imam, M. H., Sinakos, E., Gossard, A. A., Kowdley, K. V., Luketic, V. A. C., Edwyn Harrison, M., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J., Keach, J., Decook, A. C., Enders, F. & Lindor, K., Nov 2011, In : Alimentary Pharmacology and Therapeutics. 34, 10, p. 1185-1192 8 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Bilirubin
Placebos
Cholangiocarcinoma
157 Citations (Scopus)

High-dose ursodeoxycholic acid is associated with the development of colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis

Eaton, J. E., Silveira, M. G., Pardi, D. S., Sinakos, E., Kowdley, K. V., Luketic, V. A. C., Harrison, M. E., McCashland, T., Befeler, A. S., Harnois, D., Jorgensen, R., Petz, J. & Lindor, K., Sep 2011, In : American Journal of Gastroenterology. 106, 9, p. 1638-1645 8 p.

Research output: Contribution to journalArticle

Ursodeoxycholic Acid
Sclerosing Cholangitis
Ulcerative Colitis
Neoplasms
Colorectal Neoplasms
7 Citations (Scopus)

Immunoglobulin G4-associated autoimmune cholangiopathy

Lindor, K., Apr 2011, In : Gastroenterology and Hepatology. 7, 4, p. 259-261 3 p.

Research output: Contribution to journalArticle

Immunoglobulins
1 Citation (Scopus)

In reply

Reed, D. A. & Lindor, K., Aug 2011, In : Academic Medicine. 86, 8, p. 922 1 p.

Research output: Contribution to journalArticle

Leader's portrait

Lindor, K., 2011, In : Clinics and Research in Hepatology and Gastroenterology. 35, 6-7, p. 423-425 3 p.

Research output: Contribution to journalArticle

21st Century History
20th Century History
Physician Executives
Medical Faculties
Gastroenterology
70 Citations (Scopus)

Many Patients With Primary Sclerosing Cholangitis and Increased Serum Levels of Carbohydrate Antigen 19-9 Do Not Have Cholangiocarcinoma

Sinakos, E., Saenger, A. K., Keach, J., Kim, W. R. & Lindor, K., May 2011, In : Clinical Gastroenterology and Hepatology. 9, 5

Research output: Contribution to journalArticle

Sclerosing Cholangitis
Cholangiocarcinoma
Carbohydrates
Antigens
Serum